# Jade Biosciences, Inc.: Form 8-K, filed Oct 7, 2025

- Company: [Jade Biosciences, Inc.](/companies/jbio.md) (CIK 1798749)
- Form: 8-K
- Filed: 2025-10-07
- Accepted by EDGAR: Oct 7, 2025, 07:13 ET
- Period: 2025-10-03
- Accession: 0001193125-25-232562
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1798749/000119312525232562/d58004d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1798749/000119312525232562/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1798749/000119312525232562/d58004d8k.htm

Filed Oct 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-232562. Last ingested by Listed: Nov 14, 2026, 11:14 ET. No prices; not investment advice.
